Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana
2019
The emergence and transmission of multidrug
resistant(MDR) and extensively
drug resistant(XDR) Mycobacterium tuberculosis (M.tb) strains is a threat to global tuberculosis (TB) control. The early detection of
drug resistanceis critical for patient management. The aim of this study was to determine the proportion of isolates with additional second-line
resistanceamong
rifampicinand
isoniazid
resistantand MDR-TB isolates. A total of 66 M.tb isolates received at the National Tuberculosis Reference Laboratory between March 2012 and October 2013 with
resistanceto
isoniazid,
rifampicinor both were analyzed in this study. The genotypes of the M.tb isolates were determined by spoligotyping and second-line drug susceptibility testing was done using the Hain Genotype MTBDRsl line probe assay version 2.0. The treatment outcomes were defined according to the Botswana national and World Health Organization (WHO) guidelines. Of the 57 isolates analyzed, 33 (58%) were MDR-TB, 4 (7%) were additionally
resistantto flouroquinolones and 3 (5%) were
resistantto both fluoroquinolones and second-line injectable drugs. The most common fluoroquinolone
resistance-conferring mutation detected was gyrA A90V. All XDR-TB cases remained smear or culture positive throughout the treatment. Our study findings indicate the importance of monitoring
drug resistantTB cases to ensure rapid detection of second-line
drug resistance.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
-
Machine Reading By IdeaReader
28
References
4
Citations
NaN
KQI